The Biden Administration Encourages Further Expansion of Vaccines

WASHINGTON, DC (March 26, 2018) — Despite the severity of the current influenza season, the Obama Administration has announced new plans to expand the production of a key influenza vaccine and expand other public…

The Biden Administration Encourages Further Expansion of Vaccines

WASHINGTON, DC (March 26, 2018) — Despite the severity of the current influenza season, the Obama Administration has announced new plans to expand the production of a key influenza vaccine and expand other public health investments to increase the safety and effectiveness of vaccinations. The announcement comes as the US saw three consecutive weeks of above-average flu outbreaks, at a time when two major outbreaks of influenza are currently gripping the United States.

Biden Administration Calls for Expandibility of Bcl-2 Vaccine

As part of the recently released 2018-19 Budget Request for the National Institutes of Health (NIH), the Federal Government has called for expanded use of the B-12 Influenza Vaccine, which has been shown to protect against several strains of influenza.

A pilot program to increase the annual production of this unique vaccine—whose administration is significantly more efficient than a standard influenza vaccine—is planned to begin immediately. One of the important ingredients is the antigen, a protein that can signal antibodies against influenza. The administration of only the seasonal flu vaccine can lead to inhibited levels of antigen circulating in the population. Placing more antigen in each dose increases the likelihood that it will prompt a robust response.

“Health Canada has been researching whether the available B-12 Flu Vaccine should be able to be manufactured by expanded methods,” says Dr. Martin Mason, who conducted field trials of this vaccine in vulnerable groups in Peru in 2017. He will be one of the authors of the commentary I co-authored with Dr. Tania Fairclough of Health Canada.

Health Canada approved the broadening of the B-12 Flu Vaccine for mass production in Canada last year. The United States approval of expanded applications for the B-12 Flu Vaccine is a major step forward for increased use of this innovative and potentially life-saving influenza vaccine.

Shared Governance – Children’s Health and Vaccines Initiative

The administration plans to more closely align federal agencies to support state and local government commitments to protect the health and wellness of children. The public health imperative includes greater sharing of vaccines and diagnostic tools, testing, treatment, and public health education among federal agencies with a particular focus on keeping families safe and healthy.

Leave a Comment